Form 4 for PRLB Proto Labs Inc

Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001437749-22-003676 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-02-17	2022-02-15	PRLB	Bodor Robert	Pres, CEO	A - Grant	$0.00	+11.8K	36.7K	+47%	$0
DM	2022-02-17	2022-02-15	PRLB	Bodor Robert	Pres, CEO	A - Grant	$0.00	+48.7K	25.1K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-02-15	A	A	11,785	$0.00	36,667	D	—	—	(F1) Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested. (F2) Reports the total number of shares of Common Stock of the issuer held by the reporting person including 188 shares purchased on May 15, 2021 through the issuer's Employee Stock Purchase Plan program.
2	Derivative	Performance Stock Units	2022-02-15	A	A	23,570	$0.00	23,570	D	— · — to 2024-12-31	23,570 Common Stock	(F4) Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share.
3	Derivative	Employee Stock Option (right to buy)	2022-02-15	A	A	25,147	$0.00	25,147	D	$59.40 · — to 2032-02-13	25,147 Common Stock	(F3) 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested.